Bristol Myers Squibb gets FDA approval for metastatic melanoma therapy

Bristol Myers Squibb has obtained approval from the US FDA for Opdualag to treat unresectable or metastatic melanoma patients.

Related Keywords

Bristol Myers Squibb Opdualag ,Samit Hirawat ,Drug Administration ,Bristol Myers Squibb ,Bristol Myers Squibb Company ,Myers Squibb ,Menu Hover ,Subchild Level Menu Hover ,Child Level Menu Hover ,